Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy A Higgins

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Frontiers in Pharmacology|March 15, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant PropertyGuy A Higgins, Nicole K Carroll, Matt Brown, et al.
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivityTheresa M Ballard, Meike Pauly-Evers, Guy A Higgins, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonistsTorsten Hoffmann, Michael Bös, Heinz Stadler, et al.
Psychopharmacology|October 21, 2009
Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic propertyGuy A Higgins, Nathalie Breysse, Elijus Undzys, et al.
Pharmacology Research & Perspectives|February 19, 2015
Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesityGuy A Higgins, Jill Desnoyer, Annalise Van Niekerk, et al.
Pharmacology Research & Perspectives|October 23, 2024
The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsyJill C Richardson, Guy A Higgins, Neil Upton, et al.
Behavioural Brain Research|May 3, 2005
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 miceLynn A Hyde, Tatiana M Kazdoba, Mariagrazia Grilli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2006
Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouseLynn A Hyde, Nansie A McHugh, Joseph Chen, et al.
ACS Chemical Neuroscience|March 25, 2017
Studies To Examine Potential Tolerability Differences between the 5-HT<sub>2C</sub> Receptor Selective Agonists Lorcaserin and CP-809101Guy A Higgins, Leonardo B Silenieks, Amy Patrick, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Frontiers in Pharmacology|March 15, 2021
Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant PropertyGuy A Higgins, Nicole K Carroll, Matt Brown, et al.
Neuropharmacology|April 15, 2004
Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodentGuy A Higgins, Theresa M Ballard, James N C Kew, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 2, 2002
Severe impairment of NMDA receptor function in mice carrying targeted point mutations in the glycine binding site results in drug-resistant nonhabituating hyperactivityTheresa M Ballard, Meike Pauly-Evers, Guy A Higgins, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonistsTorsten Hoffmann, Michael Bös, Heinz Stadler, et al.
Psychopharmacology|October 21, 2009
Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic propertyGuy A Higgins, Nathalie Breysse, Elijus Undzys, et al.
Pharmacology Research & Perspectives|February 19, 2015
Characterization of the 5-HT2C receptor agonist lorcaserin on efficacy and safety measures in a rat model of diet-induced obesityGuy A Higgins, Jill Desnoyer, Annalise Van Niekerk, et al.
Pharmacology Research & Perspectives|October 23, 2024
The hydroxycarboxylic acid receptor HCA2 is required for the protective effect of ketogenic diet in epilepsyJill C Richardson, Guy A Higgins, Neil Upton, et al.
Behavioural Brain Research|May 3, 2005
Age-progressing cognitive impairments and neuropathology in transgenic CRND8 miceLynn A Hyde, Tatiana M Kazdoba, Mariagrazia Grilli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2006
Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouseLynn A Hyde, Nansie A McHugh, Joseph Chen, et al.
ACS Chemical Neuroscience|March 25, 2017
Studies To Examine Potential Tolerability Differences between the 5-HT<sub>2C</sub> Receptor Selective Agonists Lorcaserin and CP-809101Guy A Higgins, Leonardo B Silenieks, Amy Patrick, et al.
Pageof 8